Bristol-Myers Squibb expands care program as Bristol-Myers Squibb stock sits at EUR 54.42
Published on 10/04/2026 at 19:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
On October 1, 2026, Bristol Myers Squibb announced an expansion of its Champions in Care initiative, including a $1 million grant program; separately, Bristol-Myers Squibb stock was EUR 54.42 in weekend trading at Lang & Schwarz at 6:58 p.m. CEST on October 4, 2026. The quote was unchanged versus the EUR 54.42 close of the last Xetra trading day on October 2, 2026. The announcement was issued by Bristol Myers Squibb.
Weekend trading
Lang & Schwarz quoted the company at EUR 54.42 in weekend trading at 6:58 p.m. CEST on October 4, 2026. The price was EUR 54.42 above neither nor below the close of EUR 54.42 on October 2, 2026, representing a change of plus 0.00 percent versus that close. The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Bristol-Myers Squibb stock.
Last Xetra close
The reference price for the weekend quote was the EUR 54.42 close at Lang & Schwarz on October 2, 2026. Xetra and the primary exchanges were closed during the publication window.
Champions in Care expansion
In its October 1, 2026 release, Bristol Myers Squibb said the second-year Champions in Care campaign will create opportunities for healthcare professionals to nominate nonprofit organizations supporting medically underserved communities across the United States. The company said it will award $1 million in grants. The nomination deadline is November 30, 2026, and nomination does not guarantee funding.
Next Xetra session
The next Xetra session is scheduled for October 5, 2026.
